2-bromopalmitate has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; He, QJ; Huang, C; Qi, XT; Shao, XJ; Wang, C; Xu, T; Yang, B; Yang, XC; Ying, MD; Zhang, N; Zhu, H | 1 |
| Brambilla, R; D'Ippolito, G; Howard, GA; Roos, BA; Schiller, PC | 1 |
2 other study(ies) available for 2-bromopalmitate and Osteogenic Sarcoma
| Article | Year |
|---|---|
2-Bromopalmitate sensitizes osteosarcoma cells to adriamycin-induced apoptosis via the modulation of CHOP.
Topics: Adolescent; Adult; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Child; Doxorubicin; Drug Synergism; Female; Humans; Osteosarcoma; Palmitates; Reactive Oxygen Species; Transcription Factor CHOP; Young Adult | 2019 |
Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro.
Topics: 3T3 Cells; Adipocytes; Administration, Topical; Adolescent; Aged; Animals; Anti-Inflammatory Agents; Blotting, Northern; Cell Differentiation; Cell Line; Cells, Cultured; Cytoplasm; Down-Regulation; Female; Gap Junctions; Gene Expression Regulation, Developmental; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Lipoprotein Lipase; Male; Mice; Muscle, Skeletal; Oleic Acids; Osteoblasts; Osteosarcoma; Palmitates; Phenotype; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Spine; Time Factors; Transcription Factors; Triglycerides | 2001 |